CTRI/2013/09/004013已完成4 期
A DOUBLE BLIND PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY OF ACACIA ARABICA PHYTOPHARMACEUTICAL GEL AS AN ADJUNCT IN TREATMENT AND QUALITY OF LIFE ENHANCEMENT OF PERIODONTITIS PATIENTS. - ACA
Dr Rameshwari Singhal0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects of age 18 years or older of either gender in good general health condition
- •Subjects with mild to moderate Periodontitis (pocket depth 4-6mm)
- •Patients willing to sign Informed Consent Form.
排除标准
- •History of tobacco chewing / smoking
- •Any known clinically significant hematological, endocrine disorders, hepatic or renal diseases, cardiovascular, cerebrovascular or psychiatric diseases likely to alter the treatment outcome, or could compromise the subjectâ??s participation in the trial
- •Subjects who used medication that would interfere with the efficacy and safety objectives of the trial or who were not stabilized on any concomitant medication (continuous use) during at least three months prior to randomization.
- •Patients who participate in other study protocols
研究者
相似试验
进行中（未招募）
1 期
To study the effectiveness and safety of REN001 in PMM patients after 24 weeks of treatmentPrimary Mitochondrial MyopathyMedDRA version: 20.0Level: PTClassification code 10027710Term: Mitochondrial myopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002855-40-ITReneo Pharma LTD200
进行中（未招募）
1 期
To study the effectiveness and safety of REN001 in PMM patients after 24 weeks of treatment.Primary Mitochondrial MyopathyMedDRA version: 20.0Level: PTClassification code 10027710Term: Mitochondrial myopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002855-40-ESReneo Pharma Ltd.200
进行中（未招募）
1 期
To study the effectiveness and safety of REN001 in PMM patients after 24 weeks of treatmentPrimary Mitochondrial MyopathyMedDRA version: 20.0Level: PTClassification code 10027710Term: Mitochondrial myopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002855-40-NOReneo Pharma Ltd.200
进行中（未招募）
1 期
To study the effectiveness and safety of REN001 in PMM patients after 24 weeks of treatmentPrimary Mitochondrial MyopathyMedDRA version: 20.0Level: PTClassification code 10027710Term: Mitochondrial myopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-002855-40-FRReneo Pharma Ltd.200
进行中（未招募）
1 期
To study the effectiveness and safety of REN001 in PMM patients after 24 weeks of treatmentEUCTR2020-002855-40-HUReneo Pharma Ltd.200